[Treatment of neurogenic orthostatic hypotension by an association of tyramine and a monoamine oxidase inhibitor (author's transl)]
- PMID: 7013600
[Treatment of neurogenic orthostatic hypotension by an association of tyramine and a monoamine oxidase inhibitor (author's transl)]
Abstract
Metabolic and hormonal tests to assess plasma renin, aldosterone, and catecholamine activity were conducted in three patients with idiopathic orthostatic hypotension. Blood pressure readings were then taken in decubitus and orthostatism during treatment with 10 to 15 mg of tyramine and 30 mg of tranylcypromine. Marked functional improvement was observed, with an increase in mean blood pressure in decubitus and a less marked reduction in orthostatism avoiding the onset of severe discomfort. Therapeutic indications are limited, however, because of a possible hypertensive response.
Similar articles
-
Treatment of neurogenic orthostatic hypotension with a monoamine oxidase inhibitor and tyramine.Acta Neurol Belg. 1976;76(5-6):295-300. Acta Neurol Belg. 1976. PMID: 1007896
-
Treatment of neurogenic orthostatic hypotension with a monoamine oxidase inhibitor and tyramine.Lancet. 1976 Nov 27;2(7996):1164-7. doi: 10.1016/s0140-6736(76)91681-0. Lancet. 1976. PMID: 62995
-
Idiopathic postural hypotension: physiologic observations and report of a new mode of therapy.J Clin Invest. 1970 Jul;49(7):1341-8. doi: 10.1172/JCI106350. J Clin Invest. 1970. PMID: 5432369 Free PMC article.
-
Midodrine in neurogenic orthostatic hypotension. A new treatment.Int Angiol. 1993 Jun;12(2):125-31. Int Angiol. 1993. PMID: 7690383 Review.
-
[Catecholamines and cardiovascular diseases (author's transl)].Tanpakushitsu Kakusan Koso. 1981 Aug;26(11):1834-41. Tanpakushitsu Kakusan Koso. 1981. PMID: 7029643 Review. Japanese. No abstract available.